NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for RNAi


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Alnylam Provides Update on RNAi Pipeline, Platform, and Technology at Its R&D Day
2009 NOV 23 ... Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, is providing an update on its...
Subject: Alnylam Pharmaceuticals, Inc.
Price: $3.00
*
Bioo Scientific Launches a New Division, Bioo Therapeutics
2009 NOV 23 ... cells. This patent pending technology can revolutionize the delivery of siRNA and other RNAi agents, as well as, other more traditional drugs. "Bioo Therapeutics is ...
Subject: Drug Delivery
Price: $3.00
*
Cequent Files its First IND with FDA: CEQ508, a tkRNAi Drug Candidate in Oncology
2009 NOV 23 ... Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, has announced that it has filed its ...
Subject: Cancer
Price: $3.00
*
Data on lymphoma detailed by A. Bric and co-authors
2009 NOV 23 ... hairpin RNAs (shRNAs) capable of stably suppressing gene function by RNA interference (RNAi) can mimic tumor-suppressor-gene loss in mice," scientists writing in the journal ...
Subject: Lymphoma
Price: $3.00
*
Investigators at University of New Hampshire target neonatal disease gene therapy
2009 NOV 23 ... 'Modeling a congenital disorder of glycosylation type I in C. elegans: a genome-wide RNAi screen for N-glycosylation-dependent loci,' is now available. "Inefficient ...
Subject: Neonatal Disease Gene Therapy
Price: $3.00
*
New findings in enzyme research described from University of Mississippi Medical Center
2009 NOV 23 ... but reduced by MAO B inhibitors and 1-R-aminoindan. Furthermore, silencing TIEG2 using RNAi significantly reduces GAPDH-induced MAO B upregulation and neurotoxicity. In summary, ...
Subject: Enzyme Research
Price: $3.00
*
New pancreatic cancer study findings have been reported from F.Q. Su et al
2009 NOV 23 ... patient's samples by immunohistochemistry and determined its role in BxPC3 cells via RNAi experiment. The abilities of invasion, motility, and adhesion of BxPC3 cells were ...
Subject: Pancreatic Cancer
Price: $3.00
*
Reports from University of Iowa add new data to research in life sciences
2009 NOV 23 ... thus designated as Lithium-inducible SLC6 transporter or List. Either RNA interference (RNAi)-mediated knockdown or complete deletion of List resulted in a remarkable increase in ...
Subject: Life Sciences
Price: $3.00
*
Research from C.K. Hahn and colleagues provide new insights into proteomics
2009 NOV 23 ... differentiation via a non-EGFR mechanism. In this report, we integrated proteomic and RNAi-based strategies to identify their off-target, anti-AML mechanism. These orthogonal ...
Subject: Proteomics
Price: $3.00
*
Research from R. Komiya and co-authors yields new data on life sciences
2009 NOV 24 ... APETALA1, OsMADS14, was expressed in the floral meristem in wild-type but not in RFT1 RNAi plants, suggesting that OsMADS14 is activated by RFT1 protein in the SAM after the ...
Subject: Life Sciences
Price: $3.00
*
Researchers at University of Copenhagen target gene therapy
2009 NOV 23 ... to a study from Copenhagen, Denmark, "Selective gene silencing using RNA interference (RNAi) has been shown to be an efficient method for manipulation of cellular functions. In ...
Subject: Gene Therapy
Price: $3.00
*
Researchers from Yale University discuss findings in life sciences
2009 NOV 23 ... activity of host cell proteins of the WASP/WAVE family. Here, we used an RNAi-based genetic approach in combination with computer-assisted image analysis to ...
Subject: Life Sciences
Price: $3.00
*
Studies conducted at Tarbiat Modares University, Faculty of Basic Sciences on bladder cancer cell biology recently published
2009 NOV 23 ... in bladder carcinoma cell lines and in normal uro-epithelial cell cultures. We used an RNAi strategy to investigate the function of NS in two selected carcinoma cell lines. High NS ...
Subject: Bladder Cancer Cell Biology
Price: $3.00
*
Studies from C.E. Meacham and co-researchers update current data on lymphoma
2009 NOV 23 ... Meacham and colleagues published their study in Nature Genetics (In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma ...
Subject: Lymphoma
Price: $3.00
*
Study data from A.M. Martinez et al provide new insights into genetics
2009 NOV 24 ... by ectopic expression of a dominant negative form of Notch or by RNA interference (RNAi)-mediated repression of Notch. Conversely, overexpression of ph induces a small-eye ...
Subject: Genetics
Price: $3.00
*
Study results from A. Ohmiya and colleagues broaden understanding of science
2009 NOV 29 ... a carotenoid cleavage dioxygenase gene, CmCCD4a. Here we introduced two separate CmCCD4a RNAi constructs into 'Jimba' by Agrobacterium-mediated transformation. The ...
Subject: Science
Price: $3.00
*
Study results from National Institutes of Health update understanding of drug development
2009 NOV 23 ... to both IFN-alpha and IFN-gamma, only IFN regulatory factor 9 (IRF9)-RNA interference (RNAi) completely inhibited the antiproliferative activity of IFN-alpha among the ...
Subject: Drug Development
Price: $3.00
*
The Boston Globe names Cubist to Globe 100's Top Places to Work '09
2009 NOV 23 ... syncytial virus (RSV) infections in children using Alnylam's RNA-interference (RNAi) technology. The RSV program also includes ALN-RSV01, for which Cubist has opt-in rights ...
Subject: Cubist Pharmaceuticals, Inc.
Price: $3.00
*
University of Calcutta publishes research in plant-microbe research
2009 NOV 24 ... (GI:195542474) from A. hypogea and downregulated the kinase through RNA interference (RNAi) to understand its role during organogenesis of its characteristic aeschynomenoid ...
Subject: Plant-microbe Research
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login